pharma · Weight management · Short Bowel Syndrome
Zealand Pharma
Zealand Pharma A/S
Zealand Pharma A/S is a pharma organization headquartered in EU. Primary therapeutic focus areas include Weight management, Short Bowel Syndrome, Children with congenital hyperinsulinism, Critically Ill, Mechanically Ven
Sydmarken 11, Søborg (Copenhagen), 2860, DK HQ
1998 Founded
596 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Sydmarken 11, Søborg (Copenhagen), 2860, DK
- Founded
- 1998
- Employees
- 596
- Programs
- 18
- Drugs
- 20
- Patents
- 0
Single and multiple ascending dose of ZP9830 in healthy participants
Phase 1 · other · Autoimmune diseases
Single and multiple ascending dose of ZP9830 in healthy participants for Autoimmune diseases is a Phase 1 program (other) at Zealand Pharma A/S with 1 ClinicalTrials.gov record(s).
Internal code ZP9830-23005
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Zealand Pharma A/S
- Phase
- Phase 1
- Modality
- other
- Indication
- Autoimmune diseases
- Status
- active
- Trials
- 1